关于生物仿制药物（Biosimilar products）临床评价的探讨。1．药代动力学研究 包涵关键药代参数在内的PK可比性研究，是生物仿制药物可比性研究的一个基本构成部分，用以体...
基于36个网页-相关网页
但他也表示，这次他非常谨慎地看待新仿制药物的前景，因为生物技术药物很难仿制。
But he also said he was more cautious about the promise of generics this time, because biotech medicines were not easy to copy.
理想的仿制药在生物学上相当于品牌名称几乎所有其性质的药物近乎在同一架构，但是通常是在一个相对移动销售价格。
Generic drugs ideally are biologically equivalent to brand name name drugs with almost all its properties in nearly the same compositions, but are normally sold at a comparatively move price.
应用推荐